Solid Biosciences (SLDB) Cash from Investing Activities Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 38.24% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -22.09% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 30.54% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 6.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.30% |
| Dec 31, 2025 | -10.74% |
| Sep 30, 2025 | -71.41% |
| Jun 30, 2025 | 18.11% |
| Mar 31, 2025 | -39.72% |
| Dec 31, 2024 | 8.52% |
| Sep 30, 2024 | 46.69% |
| Jun 30, 2024 | 52.64% |
| Mar 31, 2024 | -932.19% |
| Dec 31, 2023 | 811.35% |
| Sep 30, 2023 | -575.29% |
| Jun 30, 2023 | -433.43% |
| Mar 31, 2023 | 79.73% |
| Dec 31, 2022 | 185.01% |
| Sep 30, 2022 | 55.53% |
| Jun 30, 2022 | -64.71% |
| Mar 31, 2022 | 98.79% |
| Dec 31, 2021 | 50.65% |
| Sep 30, 2021 | -273.02% |
| Jun 30, 2021 | -169.46% |
| Mar 31, 2021 | 72.10% |
| Dec 31, 2020 | 72.25% |
| Sep 30, 2020 | 77.80% |
| Jun 30, 2020 | -71.29% |
| Mar 31, 2020 | -2.68% |